The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases
Open accessAbstract
Historically, one of the key problems in neglected disease drug discovery has been identifying new and interesting chemotypes. Phenotypic screening of the malaria parasite, Plasmodium falciparum has yielded almost 30,000 submicromolar hits in recent years. To make this collection more accessible, a collection of 400 chemotypes has been assembled, termed the Malaria Box. Half of these compounds were selected based on their drug-like properties and the others as molecular probes. These can now be requested as a pharmacological test set by malaria biologists, but importantly by groups working on related parasites, as part of a program to make both data and compounds readily available. In this paper, the analysis and selection methodology and characteristics of the compounds are described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,944
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
Privileged scaffolds for library design and drug discovery
Welsch, M. E., Snyder, S. A., & Stockwell, B. R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.02.018 · Cited by 1,509
Thousands of chemical starting points for antimalarial lead identification
Gamo, F.-J., Sanz, L. M., Vidal, J., de Cozar, C., Alvarez, E., Lavandera, J.-L., Vanderwall, D. E., Green, D. V. S., Kumar, V., Hasan, S., et al. (2010) · Nature · doi:10.1038/nature09107 · Cited by 996
Property distribution of drug-related chemical databases*
Oprea, T. I. (2000) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008130001697 · Cited by 628
Chemical genetics of Plasmodium falciparum
Guiguemde, W. A., Shelat, A. A., Bouck, D., Duffy, S., Crowther, G. J., Davis, P. H., Smithson, D. C., Connelly, M., Clark, J., Zhu, F., et al. (2010) · Nature · doi:10.1038/nature09099 · Cited by 566
Delves, M., Plouffe, D., Scheurer, C., Meister, S., Wittlin, S., Winzeler, E. A., Sinden, R. E., & Leroy, D. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001169 · Cited by 377
Designing screens: how to make your hits a hit
Walters, W. P., & Namchuk, M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1063 · Cited by 374
Reactive compounds and in vitro false positives in HTS
Rishton, G. M. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01083-0 · Cited by 351
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M. C., Wu, T., Barnes, S. W., Bopp, S. E., Borboa, R., Bright, A. T., Che, J., et al. (2011) · Science · doi:10.1126/science.1211936 · Cited by 338
Genomic-scale prioritization of drug targets: the TDR Targets database
Agüero, F., Al-Lazikani, B., Aslett, M., Berriman, M., Buckner, F. S., Campbell, R. K., Carmona, S., Carruthers, I. M., Chan, A. W. E., Chen, F., et al. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2684 · Cited by 306
Matched Molecular Pairs as a Medicinal Chemistry Tool: Miniperspective
Griffen, E., Leach, A. G., Robb, G. R., & Warner, D. J. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200452d · Cited by 282
Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination
Wells, T. N. C., Burrows, J. N., & Baird, J. K. (2010) · Trends in Parasitology · doi:10.1016/j.pt.2009.12.005 · Cited by 262
Self-citationStrategic Pooling of Compounds for High-Throughput Screening
Hann, M., Hudson, B., Lewell, X., Lifely, R., Miller, L., & Ramsden, N. (1999) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci990423o · Cited by 225
The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
Maude, R. J., Pontavornpinyo, W., Saralamba, S., Aguas, R., Yeung, S., Dondorp, A. M., Day, N. P., White, N. J., & White, L. J. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-31 · Cited by 184
van Westen, G. J. P., Wegner, J. K., IJzerman, A. P., van Vlijmen, H. W. T., & Bender, A. (2011) · MedChemComm · doi:10.1039/c0md00165a · Cited by 176
Mok, S., Imwong, M., Mackinnon, M. J., Sim, J., Ramadoss, R., Yi, P., Mayxay, M., Chotivanich, K., Liong, K.-Y., Russell, B., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-391 · Cited by 169
The global pipeline of new medicines for the control and elimination of malaria
Anthony, M. P., Burrows, J. N., Duparc, S., JMoehrle, J., & Wells, T. N. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-316 · Cited by 167
Self-citationIdentification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach
Crowther, G. J., Shanmugam, D., Carmona, S. J., Doyle, M., Hertz‐Fowler, C., Berriman, M., Nwaka, S., Ralph, S. A., Roos, D. S., Voorhis, W. C. V., et al. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000804 · Cited by 159
The State of the Art in Anti-Malarial Drug Discovery and Development
Burrows, J. N., Chibale, K., & Wells, T. N. C. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795429194 · Cited by 157
Self-citationDiscriminating between Drugs and Nondrugs by Prediction of Activity Spectra for Substances (PASS)
Anzali, S., Barnickel, G., Cezanne, B., Krug, M., Filimonov, D. A., & Poroikov, V. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0010670 · Cited by 146
Global Phenotypic Screening for Antimalarials
Guiguemde, W. A., Shelat, A. A., Garcia-Bustos, J., Diagana, T. T., Gamo, F., & Guy, R. K. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.01.004 · Cited by 143
Public Domain Databases for Medicinal Chemistry
Nicola, G., Liu, T., & Gilson, M. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300501t · Cited by 100
The Next Opportunity in Anti-Malaria Drug Discovery: The Liver Stage
Derbyshire, E. R., Mota, M. M., & Clardy, J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002178 · Cited by 70
Gradual in Silico Filtering for Druglike Substances
Schneider, N., Jäckels, C., Andrés, C., & Hutter, M. C. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700351y · Cited by 61
Library Enhancement through the Wisdom of Crowds
Hack, M. D., Rassokhin, D. N., Buyck, C., Seierstad, M. J., Skalkin, A., ten Holte, P., Jones, T. K., Mirzadegan, T., & Agrafiotis, D. K. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200446y · Cited by 36
Public Domain Databases for Medicinal Chemistry
Nicola, G., Liu, T., & Gilson, M. K. (2013) · Methods and principles in medicinal chemistry · doi:10.1002/9783527655984.ch02 · Cited by 7
Cited by
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
The ChEMBL bioactivity database: an update
Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Krüger, F. A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1031 · Cited by 1,492
Cowman, A. F., Healer, J., Marapana, D., & Marsh, K. (2016) · Cell · doi:10.1016/j.cell.2016.07.055 · Cited by 890
New developments in anti-malarial target candidate and product profiles
Burrows, J. N., Duparc, S., Gutteridge, W. E., Hooft van Huijsduijnen, R., Kaszubska, W., Macintyre, F., Mazzuri, S., Möhrle, J. J., & Wells, T. N. C. (2017) · Malaria Journal · doi:10.1186/s12936-016-1675-x · Cited by 520
Self-citationVan Voorhis, W. C., Adams, J. H., Adelfio, R., Ahyong, V., Akabas, M. H., Alano, P., Alday, A., Alemán Resto, Y., Alsibaee, A., Alzualde, A., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005763 · Cited by 435
Self-citation
Metadata
- Authors
- Spangenberg, T., Burrows, J. N., Kowalczyk, P., McDonald, S., Wells, T. N. C., & Willis, P.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-06-17
- Volume
- 8
- Issue
- 6
- Pages
- e62906
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2000388030
- Cited by
- 341
- References
- 29
- FWCI
- 35.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.